Big Pharma took another hit last month when some studies were released showing that two anticholesterol drugs, Zetia and Vytorin, were ineffective in lowering the risk of heart disease. These drugs did approximately 5 billion dollars in business last year, mainly because they are safer than other more proven anticholesterol […]